—#182392

Product

BD Alaris System. The EtCO2 module is a capnograph indicated for continuous, noninvasive monitoring of end tidal carbon dioxide (EtCO2), fractional inspired carbon dioxide (FiCO2) and respiratory rate (RR). The EtCO2 module and disposables are indicated for use with intubated and nonintubated adult, pediatric and neonatal patients. It is not intended for direct connection to ventilator or breathing systems. Only one EtCO2 module can be connected to the Alaris System.

FDA product code: PHC — Infusion Safety Management Software
Device class: Class 2
Medical specialty: General Hospital
510(k) numbers: K133532
Affected lot / code info: Model: EtCO2 8300; Lot/Serial numbers: 10002682711, 10002720508, 1000287042, 10002882569

Why it was recalled

Infusion pump component defect may result in interruption of patient monitoring

Root cause (FDA determination)

Vendor change control

Action the firm took

On 8/4/2020,the firm sent an "Urgent Medical Device Recall" letter to customers with FedEX tracking. A customer response form is included with the letter that the customer is instructed to email or fax back to the firm. Returned response forms will be reconciled with the customer list. A response card will be included with the customer letter that is to be mailed, emailed or faxed back to the firm and will be reconciled with the customer list. Customers that do not respond to the initial mailing will be contacted up to a total of 3 times. The firm's Customer Response Form provided E-mail address as : BDRC21@bd.com and fax no.: 1-312-949-0437. The firm instructed their customers to contact the recall support center at 1-888-562-6018 to schedule remediation of recalled modules at no charge. The firm provided an additional phone numbers and E-mail addresses as: (i) 888-812-3266 and Email: customerfeedback@bd.com for Product Complaints; (ii) 888-562-6018, SupportCenter@bd.com for Recall Related Questions and (iii) 888-812-3229, E-mail: DL-US-INF-TechSupport@bd.com Additionally, any adverse reactions experienced with the use of this product, and/or quality problems should also be reported to the FDAs MedWatch Program by: " Web: MedWatch website at www.fda.gov/medwatch " Phone: 1-800-FDA-1088 " Fax: 1-800-FDA-0178, or by " Mail: MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787

Recalling firm

Firm: CareFusion 303, Inc.
Address: 10020 Pacific Mesa Blvd, San Diego, California 92121-4386

Distribution

Distribution pattern: U.S. Nationwide distribution including in the states of AZ, CA, FL, GA, IA, ID, IL, KS, LA, MI, MN, MO, MS, MT, NC, NE, NV, NY, OH, PA, SC, TX, WA, WI. OUS.: None

Timeline

Recall initiated: 2020-08-04
Status: —

Source: openFDA Device Recall endpoint. Recall record ID #182392. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.